Emerald Mutual Fund Advisers Trust’s Palvella Therapeutics PVLA Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.8M	Buy	129,847 +24,027	+23%	+$2.92M	0.7%	64
2026 Q1	$13.2M	Buy	+105,820	New	+$11M	0.64%	69
2015 Q4	–	Sell	-11,858	Closed	-$1.74M	–	297
2015 Q3	$1.74M	Buy	11,858 +538	+5%	+$120K	0.11%	157
2015 Q2	$2.49M	Buy	+11,320	New	+$2.49M	0.19%	120

Other funds holding PVLA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's PVLA Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust increased its Palvella Therapeutics (PVLA) stake by 23% in Q2 2026, buying an estimated $2.92M and bringing the position to 129,847 shares worth $19.8M. The position accounts for 0.7% of the portfolio, ranked #64.

Emerald Mutual Fund Advisers Trust first reported a position in PVLA in Q2 2015 and has held it in 4 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Emerald Mutual Fund Advisers Trust held 129,847 shares of Palvella Therapeutics worth $19.8M as of Q2 2026.
Emerald Mutual Fund Advisers Trust bought 24,027 Palvella Therapeutics shares in Q2 2026, an estimated $2.92M.
Palvella Therapeutics made up 0.7% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #64 holding.
Emerald Mutual Fund Advisers Trust first reported a position in Palvella Therapeutics in Q2 2015 and has held it in 4 quarters since.
197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.